ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • Subscription
  • Newsletter
  • Advertising
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPECIALS

Special Summer 2024

Euro BioFairs Compass

Guide to Life Sciences Events in the second half year of 2024 more ➔

Special Spring 2024

Bioprocessing & Precision Fermentation

The biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These … more ➔

ADVERTISEMENT

Special Winter 2023

Euro BioFairs Compass

Guide to Life Sciences Events in the first half year of 2024 more ➔

Special Autumn 2023

CROs & CDMOs

Since 2006, the share of biomanufacturers producing everything in-house have declined from 57.6% to 34.9% in 2022. According to biopharmaceutical companies, the percentage is to decrease to 20% by 2026, … more ➔

Special Summer 2023

Euro BioFairs Compass

2nd half year 2023 more ➔

Page 2 of 212

LATEST NEWS

Joan Perelló, Managing Partner at Ysios Capital, will lead the initiativeYsios Capital

Ysios Capital launches InceptionBio: €100m for Sp...

Building of the European Parliament in Brussels123rf.com/Paul Grecaud

EIF starts €15bn fund-of-funds for scaling Europe...

a-chosen-soul-DIFqU-oBCg4-unsplashUnsplash+

TenBoron lands €7.6m EU grant for precision radio...

ADVERTISEMENT

MAGAZINE

1 / 4
10/3/26 mw: Satz, PDF an JE, danach zu Andi

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

2 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

3 / 4
EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

4 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

SPONSORED PUBLICATION

TW26_Infografik_Advertorial_115x65mm--2
Life Sciences Innovations Made in Europe

Research and Innovation as a Competitive Advantage – Legal framework for Life Sciences made in Europe

Research and innovation are considered key resources for European competitiveness – and essential location factors for research-intensive industries such as the Life Sciences. The European Union … more ➔

newsletter_link
Knowbio GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top